ReleaseWire Connect

A new report published by Allied Market Research titled, "Global Continuous Glucose Monitoring Systems Market by Components, Demographics, and End UserGlobal Opportunity Analysis and Industry Forecast, 20142022, projects that the global continuous glucose monitoring systems (CGMS) market would reach $6,238 million by 2022 from $589 millionin 2015, growing at a CAGR of 39.9% during the forecast period. Sensors segment is estimated to dominate the CGMS market throughout the analysis period. Majorityof the global CMGS market share was captured by U.S. in 2015.

Neuroprosthetics Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $14 billion by 2020, registering a CAGR of 15.8% during the period 2016-2020. High growth segments such as Visual neuroprosthetics/retinal implants and applications such as Parkinson's disease, Overactive Bladder Syndrome and Epilepsy are expected to contribute substantially to the growth of the overall global Neuroprosthetics market. Motor Prosthetics holds the largest share within Neuroprosthetics devices market segment whereas Sacral Cord Stimulation (SCS) would maintain the leading market position through 2020, within technology segment.

According to a new report published by Allied Market Research, titled, Fabric Wash and Care Market by Product Types and Application: Global Opportunity Analysis and Industry Forecast, 2014-2022, the fabric wash and care market was valued at $77 billion in 2015 and is projected to reach $112 billion by 2022, growing at a CAGR of 5.6% from 2016 to 2022. In 2015, detergent segment dominated the market, whereas fabric softener/conditioner is anticipated to exhibit faster growth over the forecast period.

Global Smart Inhalers Market states that the market was $5.8 million in 2015 and is expected to reach $191 million by 2022, growing at a CAGR of 63.3% from 2016 to 2022, according to new research published by Allied Market Research. The inhalers segment captured majority share in 2015, whereas nebulizers segment is projected to grow at fastest CAGR of 64.1% during the forecast period. North America, which accounted for around two-fifths share in 2015, is expected to maintain its lead throughout.

Radiofrequency Ablation Devices Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $3,785 million by 2022, registering a CAGR of 11.8% during the period 2016-2022. The disposable devices segment dominated the market in 2015 and is expected to lead throughout analysis period.

Pediatric Ultrasound Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $332 million by 2022, registering a CAGR of 4% during the period 2016-2022. The adolescents (13-19 years) group led with one-fourth share of the overall market in 2015, and is expected to maintain its position throughout.

Global Biomaterials Market is expected to reach $139 billion by 2022, from $62 billion in 2015, growing at a CAGR of 11.8% from 2016 to 2022, according to Allied Market Research. Metallic biomaterials segment is expected to contribute significantly to the global market revenue until 2022. North America held the leading position in the global market in 2015, and is expected to maintain its lead throughout the study period.

According to a new report published by Allied Market Research, titled, Nano Programmable Logic Controller (PLC) Market by Component, Service, Type, and Industry Vertical: Global Opportunity Analysis and Industry Forecast, 2017-2023, the nano programmable logic controller (PLC) market was valued at $2,585 million in 2016, and is projected to reach $4,250 million by 2023, growing at a CAGR of 7.0% from 2017 to 2023. The Processor segment held nearly half of the total market in 2016.

Extremity Reconstruction Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $3,041 million by 2022, registering a CAGR of 7.5% during the period 2016-2022. Shoulder reconstruction segment, which accounted for more than 70% in 2015, is expected to dominate the global market throughout the forecast period. North America held the leading position in 2015, and is expected to maintain this trend throughout.

Next Generation Diabetes Therapy and Drug Delivery Market report, published by Allied Market Research, forecasts that the global market was valued at $617 million in 2015 and is expected to garner $9,673 million by 2022, registering a CAGR of 41.1% during the forecast period 2016 - 2023. North America is the highest contributor in the next generation diabetes therapy and drug delivery market; however, Asia-Pacific is witnessing the highest growth rate.